                               SEQUENCE LISTING

<110> KITE PHARMA, INC.
 
<120> IMMUNOTHERAPIES

<130> K-1108-WO-PCT

<140> PCT/US2022/016961
<141> 2022-02-18

<150> 63/274,342
<151> 2021-11-01

<150> 63/250,634
<151> 2021-09-30

<150> 63/227,733
<151> 2021-07-30

<150> 63/215,838
<151> 2021-06-28

<150> 63/210,962
<151> 2021-06-15

<150> 63/196,620
<151> 2021-06-03

<150> 63/151,710
<151> 2021-02-20

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Gly Gly Gly Ser 
1               5   


